Bliss GVS Pharma Quarterly Results for Trading Insights

BLISSGVS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹29 Cr
QSept 2025
Quarterly Results

Bliss GVS Pharma Quarterly Results Key Highlights

  • Revenue of ₹253 Cr in Sept 2025 (+20.5% vs Mar 2025, +13.5% vs Sept 2024)
  • Net Profit of ₹29 Cr in Sept 2025 (+70.6% vs Mar 2025, +11.5% vs Sept 2024)
  • EBITDA of ₹52 Cr in Sept 2025 (+57.6% vs Mar 2025)
  • Operating Margin of 18.0% in Sept 2025 (+7.0pp vs Mar 2025)
  • Earnings Per Share of ₹2.58 in Sept 2025 (+75.5% vs Mar 2025)

Bliss GVS Pharma Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 253 210 243 237 223 20.5% 13.5%
Net Profit (₹ Cr) 29 17 44 25 26 - -
EBITDA (₹ Cr) 52 33 77 51 47 - -
EPS (₹) 2.58 1.47 4.08 2.20 2.31 - -
Operating Margin (%) 18.0% 11.0% 20.0% 15.0% 19.0% - -

Bliss GVS Pharma Share Price Trend Around Quarterly Results

Visualize Bliss GVS Pharma's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Bliss GVS Pharma

Additional stock information and data for BLISSGVS

Bliss GVS Pharma share price today
BLISSGVS price earnings ratio
BLISSGVS yearly price range

Profitability Ratios

Profit Margin 11.5%
EBITDA Margin 20.6%
Operating Margin 18.0%
ROE (Annual) 10.6%

Balance Sheet Highlights

Total Assets ₹1,301 Cr
Total Equity ₹1,092 Cr
Current Assets ₹827 Cr
Current Liabilities ₹37 Cr

Cash Flow Analysis

Operating Cash Flow ₹106 Cr
Investing Cash Flow ₹-75 Cr
Financing Cash Flow ₹-30 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹254.07
Exchange NSE
Last Updated Apr 09, 2026

Revenue Trend (₹ Cr)

Dec 2025 237
Jun 2025 243
Mar 2025 210
Sept 2025 253

Net Profit Trend (₹ Cr)

Dec 2025 25
Jun 2025 44
Mar 2025 17
Sept 2025 29

Operating Margin Trend (%)

Dec 2025 15.0%
Jun 2025 20.0%
Mar 2025 11.0%
Sept 2025 18.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Bliss GVS Pharma quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹406,351.37 Cr 1717.1 14,875 3,125 +10.8% - 21.0% 132.1
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5952.5 2,860 689 +7.1% - 24.1% 229.2
Torrent Pharmaceuti…
Sept 2025 		₹134,945.00 Cr 4094.5 3,219 591 +11.3% - 18.4% 233.4
Lupin
Sept 2025 		₹102,578.78 Cr 2295.1 6,921 1,485 +23.2% - 21.5% 70.9
Dr Reddys Laborator…
Sept 2025 		₹101,601.09 Cr 1211.9 9,135 1,337 +1.1% - 14.6% 74.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores